
Jupiter Diagnostics
Jupiter Diagnostics has developed a diagnostic platform.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | £2.5m | Series A | |
Total Funding | 000k |
Related Content
Jupiter Diagnostics, founded in 2015, is a developer of nano-crystal labeled technology aimed at providing high-quality, affordable blood testing for medical diagnostics. The company is headquartered in London, United Kingdom, and operates within the Laboratory Services (Healthcare) industry. The firm was established to address the inefficiencies and costs associated with traditional blood testing by moving the process closer to clinicians and patients, such as in wards, clinics, and pharmacies. This approach facilitates more convenient and ready access to common blood tests, enabling faster and better-informed healthcare decisions.
The company was founded by Chris Ball, who now serves as CEO. His background includes launching point-of-care diagnostic tests for Johnson & Johnson in Europe, serving as CEO of a Boston-based biotech company, and working as a venture capital investor and a medical doctor. He has successfully raised over £40 million for companies he has supported or led. Other key figures include CTO Gareth Jones, who has extensive experience in creating and advising on novel diagnostic technologies for UK firms, and Chairman Richard Sandberg, who founded Dianon Systems, a major US pathology service later sold to LabCorp.
Jupiter Diagnostics' core offering is the Calisto Multitest Reader, a portable, hand-held, rechargeable point-of-care device designed to deliver lab-quality blood test results within 10 minutes. The device utilizes fluorescence detection to measure up to eight analytes simultaneously. It was developed to be user-friendly with an intuitive process and a clear graphical user interface that allows clinicians remote and secure data access via a web service. The business aims to provide clinicians access to reliable and timely blood tests, initially focusing on fertility clinics, to allow for quicker diagnosis and treatment. Jupiter Diagnostics has raised a total of $2.48M in funding.
Keywords: point-of-care diagnostics, blood testing, medical devices, healthcare technology, clinical diagnostics, laboratory services, nano-crystal technology, fluorescence detection, Calisto Multitest Reader, portable diagnostics
Tech stack
Investments by Jupiter Diagnostics
Edit